PUBLIKATIONSLISTE und Liste der Vorträge - EPC - European ...

37. Nixdorff U, Matschke C, Winklmaier M, Flachskampf FA, Ludwig J, Pohle K, Land M,
Gefeller O, Daniel WG. Native tissue second harmonic imaging improves endocardial and
epicardial border definition in dobutamine stress echocardiography. Eur J Echocardiography
2001; 2:52-61.
38. Voigt J-U, Lindenmeier G, Werner D, Flachskampf FA, Nixdorff U, Hatle L, Sutherland
GR, Daniel WG. Strain rate imaging for the assessment of preload-dependent changes in
regional left ventricular diastolic longitudinal function. J Am Soc Echocardiogr 2002, 15:13-9.
39. Stellbrink C, Hanrath P, Nixdorff U, Hofmann T, Lehmacher W, Kühle K, Fetsch T, Grewe
R, Schmidt-Lucke J-A on behalf of the ACE Study Group. Low molecular weight heparin for
prevention of thromboembolic complications in cardioversion - rationale and design of the
ACE study (Anticoagulation in Cardioversion using Enoxaparin). Z Kardiol 2002; 91:249-54.
40. Zimmermann WH, Didié M, Wasmeier GH, Nixdorff U, Hess A, Melnychenko I, Boy O,
Neuhuber WL, Weyand M, Eschenhagen T. Cardiac grafting of engineered heart tissue.
Circulation 2002; 106 (Suppl I):I-151-I-157.
41. Giesler T, Lamprecht S, Voigt J-U, Ropers D, Pohle K, Ludwig J, Flachskampf FA, Daniel
WG, Nixdorff U. Long term follow up after deferral of revascularisation in patients with
intermediate coronary stenoses and negative dobutamine stress echocardiography. Heart
2002, 88:645-6.
42. Voigt J-U, Exner B, Schmiedehausen K, Huchzermeyer C, Reulbach U, Nixdorff U,
Platsch G, Kuwert T, Daniel WG, Flachskampf FA. Strain rate imaging during dobutamine
stress echocardiography provides objective evidence of inducible ischemia. Circulation 2003;
107:2120-6.
43. Voigt J-U, Lindenmeier G, Exner B, Regenfus M, Werner D, Reulbach U, Nixdorff U,
Flachskampf FA, Daniel WG. Incidence and characteristics of segmental postsystolic
longitudinal shortening in normal, acutely ischemic, and scarred myocardium. J Am Soc
Echocardiogr 2003; 16:415-23.
44. Stellbrink C, Nixdorff U, Hofmann T, Lehmacher W, Daniel WG, Hanrath P, Geller C,
Mugge A, Sehnert W, Schmidt-Lucke C, Schmidt-Lucke JA; Anticoagulation in Cardioversion
using Enoxaparin study group. Use of subcutaneous enoxaparin compared to
intravenous heparin and or phenprocoumon in the setting of cardioversion – the ACE study
(Anticoagulation in Cardioversion using Enoxaparin). Card Electrophysiol Rev 2003; 7:382-6.
6